Lifelong Brain-Stimulating Practices Leads to Lower Alzheimer’s Protein Levels
By MedImaging International staff writers Posted on 01 Feb 2012 |

Image: PET scans reveal amyloid plaques, which appear as warm colors such as red and orange. The middle scan is from a person with no symptoms of cognitive problems, but with evident levels of amyloid plaque in the brain (Photo courtesy of Susan Landau and William Jagust).
Neuroimaging scans have revealed that individuals with no symptoms of Alzheimer’s who engaged in cognitively stimulating activities throughout their lives had fewer deposits of beta-amyloid, a destructive protein that is major characteristic of the disease.
Whereas earlier studies have implied that engaging in mentally stimulating activities--such as reading, writing, and playing games--may help stave off Alzheimer’s disease later in life, this new study identifies the biologic target at play. This finding could guide future research into effective prevention strategies.
“These findings point to a new way of thinking about how cognitive engagement throughout life affects the brain,” said study lead investigator Dr. William Jagust, a professor with joint appointments at University of California, Berkeley’s (USA) Helen Wills Neuroscience Institute, the School of Public Health and Lawrence Berkeley National Laboratory. “Rather than simply providing resistance to Alzheimer’s, brain-stimulating activities may affect a primary pathological process in the disease. This suggests that cognitive therapies could have significant disease-modifying treatment benefits if applied early enough, before symptoms appear.”
The new study, published January 23, 2012, in the journal Archives of Neurology, places the focus on amyloid--protein fibers folded into tangled plaques that accumulate in the brain. Beta-amyloid is considered the top culprit in the pathology of Alzheimer’s disease; therefore, finding a way to reduce its development has become a major new direction of research.
The researchers noted that the buildup of amyloid can also be influenced by genes and aging-- one-third of people age 60 and over have some amyloid deposits in their brain--but how much reading and writing one does is under each individual’s control. “This is the first time cognitive activity level has been related to amyloid buildup in the brain,” said study lead author Dr. Susan Landau, research scientist at the Helen Wills Neuroscience Institute and the Berkeley Lab. “Amyloid probably starts accumulating many years before symptoms appear. So it’s possible that by the time you have symptoms of Alzheimer’s, like memory problems, there is little that can be done to stop disease progression. The time for intervention may be much sooner, which is why we’re trying to identify whether lifestyle factors might be related to the earliest possible changes.”
The researchers asked 65 healthy, cognitively normal adults aged 60 and over (median age was 76) to rate how frequently they participated in such mentally stilmulating activities as going to the library, reading books or newspapers, and writing letters or email. The questions focused on various points in life from age six to the present.
The participants took part in extensive neuropsychologic testing to evaluate memory and other cognitive functions, and received positron emission tomography (PET) scans at the Berkeley Lab using a new tracer called Pittsburgh compound B that was developed to visualize amyloid. The results of the brain scans of healthy older individuals with various levels of lifetime cognitive activity were compared with those of 10 patients diagnosed with Alzheimer’s disease and 11 healthy individuals in their 20s.
The researchers discovered a significant association between higher levels of cognitive activity over a lifetime and lower levels of beta-amyloid in the PET scans. They analyzed the impact of other factors such as memory function, physical activity, self-rated memory ability, level of education and gender, and found that lifelong cognitive engagement was independently linked to amyloid deposition.
Significantly, the researchers did not find a strong connection between amyloid deposition and levels of current cognitive activity alone. “What our data suggest is that a whole lifetime of engaging in these activities has a bigger effect than being cognitively active just in older age,” said Dr. Landau.
The researchers stressed that the study does not contradict the benefits of jolting brain activity in later years. “There is no downside to cognitive activity. It can only be beneficial, even if for reasons other than reducing amyloid in the brain, including social stimulation and empowerment,” said Dr. Jagust. “And actually, cognitive activity late in life may well turn out to be beneficial for reducing amyloid. We just haven’t found that connection yet.”
Other researchers involved in the study were from the University California (UC) San Francisco’s (USA) Memory and Aging Center and department of neurology, and Rush University Medical Center’s Alzheimer’s Disease Center (Chicago, IL, USA).
Related Links:
University of California, Berkeley
University California, San Francisco
Rush University Medical Center’s Alzheimer’s Disease Center
Whereas earlier studies have implied that engaging in mentally stimulating activities--such as reading, writing, and playing games--may help stave off Alzheimer’s disease later in life, this new study identifies the biologic target at play. This finding could guide future research into effective prevention strategies.
“These findings point to a new way of thinking about how cognitive engagement throughout life affects the brain,” said study lead investigator Dr. William Jagust, a professor with joint appointments at University of California, Berkeley’s (USA) Helen Wills Neuroscience Institute, the School of Public Health and Lawrence Berkeley National Laboratory. “Rather than simply providing resistance to Alzheimer’s, brain-stimulating activities may affect a primary pathological process in the disease. This suggests that cognitive therapies could have significant disease-modifying treatment benefits if applied early enough, before symptoms appear.”
The new study, published January 23, 2012, in the journal Archives of Neurology, places the focus on amyloid--protein fibers folded into tangled plaques that accumulate in the brain. Beta-amyloid is considered the top culprit in the pathology of Alzheimer’s disease; therefore, finding a way to reduce its development has become a major new direction of research.
The researchers noted that the buildup of amyloid can also be influenced by genes and aging-- one-third of people age 60 and over have some amyloid deposits in their brain--but how much reading and writing one does is under each individual’s control. “This is the first time cognitive activity level has been related to amyloid buildup in the brain,” said study lead author Dr. Susan Landau, research scientist at the Helen Wills Neuroscience Institute and the Berkeley Lab. “Amyloid probably starts accumulating many years before symptoms appear. So it’s possible that by the time you have symptoms of Alzheimer’s, like memory problems, there is little that can be done to stop disease progression. The time for intervention may be much sooner, which is why we’re trying to identify whether lifestyle factors might be related to the earliest possible changes.”
The researchers asked 65 healthy, cognitively normal adults aged 60 and over (median age was 76) to rate how frequently they participated in such mentally stilmulating activities as going to the library, reading books or newspapers, and writing letters or email. The questions focused on various points in life from age six to the present.
The participants took part in extensive neuropsychologic testing to evaluate memory and other cognitive functions, and received positron emission tomography (PET) scans at the Berkeley Lab using a new tracer called Pittsburgh compound B that was developed to visualize amyloid. The results of the brain scans of healthy older individuals with various levels of lifetime cognitive activity were compared with those of 10 patients diagnosed with Alzheimer’s disease and 11 healthy individuals in their 20s.
The researchers discovered a significant association between higher levels of cognitive activity over a lifetime and lower levels of beta-amyloid in the PET scans. They analyzed the impact of other factors such as memory function, physical activity, self-rated memory ability, level of education and gender, and found that lifelong cognitive engagement was independently linked to amyloid deposition.
Significantly, the researchers did not find a strong connection between amyloid deposition and levels of current cognitive activity alone. “What our data suggest is that a whole lifetime of engaging in these activities has a bigger effect than being cognitively active just in older age,” said Dr. Landau.
The researchers stressed that the study does not contradict the benefits of jolting brain activity in later years. “There is no downside to cognitive activity. It can only be beneficial, even if for reasons other than reducing amyloid in the brain, including social stimulation and empowerment,” said Dr. Jagust. “And actually, cognitive activity late in life may well turn out to be beneficial for reducing amyloid. We just haven’t found that connection yet.”
Other researchers involved in the study were from the University California (UC) San Francisco’s (USA) Memory and Aging Center and department of neurology, and Rush University Medical Center’s Alzheimer’s Disease Center (Chicago, IL, USA).
Related Links:
University of California, Berkeley
University California, San Francisco
Rush University Medical Center’s Alzheimer’s Disease Center
Latest Nuclear Medicine News
- Novel PET Imaging Approach Offers Never-Before-Seen View of Neuroinflammation
- Novel Radiotracer Identifies Biomarker for Triple-Negative Breast Cancer
- Innovative PET Imaging Technique to Help Diagnose Neurodegeneration
- New Molecular Imaging Test to Improve Lung Cancer Diagnosis
- Novel PET Technique Visualizes Spinal Cord Injuries to Predict Recovery
- Next-Gen Tau Radiotracers Outperform FDA-Approved Imaging Agents in Detecting Alzheimer’s
- Breakthrough Method Detects Inflammation in Body Using PET Imaging
- Advanced Imaging Reveals Hidden Metastases in High-Risk Prostate Cancer Patients
- Combining Advanced Imaging Technologies Offers Breakthrough in Glioblastoma Treatment
- New Molecular Imaging Agent Accurately Identifies Crucial Cancer Biomarker
- New Scans Light Up Aggressive Tumors for Better Treatment
- AI Stroke Brain Scan Readings Twice as Accurate as Current Method
- AI Analysis of PET/CT Images Predicts Side Effects of Immunotherapy in Lung Cancer
- New Imaging Agent to Drive Step-Change for Brain Cancer Imaging
- Portable PET Scanner to Detect Earliest Stages of Alzheimer’s Disease
- New Immuno-PET Imaging Technique Identifies Glioblastoma Patients Who Would Benefit from Immunotherapy
Channels
Radiography
view channel
World's Largest Class Single Crystal Diamond Radiation Detector Opens New Possibilities for Diagnostic Imaging
Diamonds possess ideal physical properties for radiation detection, such as exceptional thermal and chemical stability along with a quick response time. Made of carbon with an atomic number of six, diamonds... Read more
AI-Powered Imaging Technique Shows Promise in Evaluating Patients for PCI
Percutaneous coronary intervention (PCI), also known as coronary angioplasty, is a minimally invasive procedure where small metal tubes called stents are inserted into partially blocked coronary arteries... Read moreMRI
view channel
AI Tool Tracks Effectiveness of Multiple Sclerosis Treatments Using Brain MRI Scans
Multiple sclerosis (MS) is a condition in which the immune system attacks the brain and spinal cord, leading to impairments in movement, sensation, and cognition. Magnetic Resonance Imaging (MRI) markers... Read more
Ultra-Powerful MRI Scans Enable Life-Changing Surgery in Treatment-Resistant Epileptic Patients
Approximately 360,000 individuals in the UK suffer from focal epilepsy, a condition in which seizures spread from one part of the brain. Around a third of these patients experience persistent seizures... Read more
AI-Powered MRI Technology Improves Parkinson’s Diagnoses
Current research shows that the accuracy of diagnosing Parkinson’s disease typically ranges from 55% to 78% within the first five years of assessment. This is partly due to the similarities shared by Parkinson’s... Read more
Biparametric MRI Combined with AI Enhances Detection of Clinically Significant Prostate Cancer
Artificial intelligence (AI) technologies are transforming the way medical images are analyzed, offering unprecedented capabilities in quantitatively extracting features that go beyond traditional visual... Read moreUltrasound
view channel
AI Identifies Heart Valve Disease from Common Imaging Test
Tricuspid regurgitation is a condition where the heart's tricuspid valve does not close completely during contraction, leading to backward blood flow, which can result in heart failure. A new artificial... Read more
Novel Imaging Method Enables Early Diagnosis and Treatment Monitoring of Type 2 Diabetes
Type 2 diabetes is recognized as an autoimmune inflammatory disease, where chronic inflammation leads to alterations in pancreatic islet microvasculature, a key factor in β-cell dysfunction.... Read moreGeneral/Advanced Imaging
view channel
AI-Powered Imaging System Improves Lung Cancer Diagnosis
Given the need to detect lung cancer at earlier stages, there is an increasing need for a definitive diagnostic pathway for patients with suspicious pulmonary nodules. However, obtaining tissue samples... Read more
AI Model Significantly Enhances Low-Dose CT Capabilities
Lung cancer remains one of the most challenging diseases, making early diagnosis vital for effective treatment. Fortunately, advancements in artificial intelligence (AI) are revolutionizing lung cancer... Read moreImaging IT
view channel
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read moreIndustry News
view channel
GE HealthCare and NVIDIA Collaboration to Reimagine Diagnostic Imaging
GE HealthCare (Chicago, IL, USA) has entered into a collaboration with NVIDIA (Santa Clara, CA, USA), expanding the existing relationship between the two companies to focus on pioneering innovation in... Read more
Patient-Specific 3D-Printed Phantoms Transform CT Imaging
New research has highlighted how anatomically precise, patient-specific 3D-printed phantoms are proving to be scalable, cost-effective, and efficient tools in the development of new CT scan algorithms... Read more
Siemens and Sectra Collaborate on Enhancing Radiology Workflows
Siemens Healthineers (Forchheim, Germany) and Sectra (Linköping, Sweden) have entered into a collaboration aimed at enhancing radiologists' diagnostic capabilities and, in turn, improving patient care... Read more